Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 10, 2023

BUY
$0.56 - $1.07 $840 - $1,605
1,500 Added 12.33%
13,663 $8,000
Q1 2022

Apr 11, 2022

BUY
$1.63 - $2.55 $3,525 - $5,515
2,163 Added 21.63%
12,163 $29,000
Q1 2021

Apr 14, 2021

BUY
$2.2 - $5.05 $22,000 - $50,500
10,000 New
10,000 $36,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Soundmark Wealth Management, LLC Portfolio

Follow Soundmark Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soundmark Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soundmark Wealth Management, LLC with notifications on news.